메뉴 건너뛰기




Volumn 83, Issue 9, 2014, Pages 1655-1664

Very early indicators of response to systemic therapy in lymphoma patients based on alterations in water diffusivity - A preliminary experience in 20 patients undergoing whole-body diffusion-weighted imaging

Author keywords

DWI; Lymphoma; MRI; Response evaluation

Indexed keywords

ALEMTUZUMAB; BENDAMUSTINE; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUDARABINE; IFOSFAMIDE; PREDNISOLONE; PREDNISONE; PROCARBAZINE; RITUXIMAB; VINCRISTINE;

EID: 84906319973     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2014.05.027     Document Type: Article
Times cited : (31)

References (27)
  • 1
    • 33749632375 scopus 로고    scopus 로고
    • The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma
    • E. Giné, S. Montoto, F. Bosch, L. Arenillas, S. Mercadal, and N. Villamor et al. The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma Ann Oncol 17 10 2006 1539 1545
    • (2006) Ann Oncol , vol.17 , Issue.10 , pp. 1539-1545
    • Giné, E.1    Montoto, S.2    Bosch, F.3    Arenillas, L.4    Mercadal, S.5    Villamor, N.6
  • 2
    • 79960116662 scopus 로고    scopus 로고
    • SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma
    • R.O. Casasnovas, M. Meignan, A. Berriolo-Riedinger, S. Bardet, A. Julian, and C. Thieblemont et al. SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma Blood 118 1 2011 37 43
    • (2011) Blood , vol.118 , Issue.1 , pp. 37-43
    • Casasnovas, R.O.1    Meignan, M.2    Berriolo-Riedinger, A.3    Bardet, S.4    Julian, A.5    Thieblemont, C.6
  • 3
    • 63849205243 scopus 로고    scopus 로고
    • Prognostic value of interim 18F-FDG PET in patients with diffuse large B-Cell lymphoma: SUV-based assessment at 4 cycles of chemotherapy
    • E. Itti, C. Lin, J. Dupuis, G. Paone, D. Capacchione, and A. Rahmouni et al. Prognostic value of interim 18F-FDG PET in patients with diffuse large B-Cell lymphoma: SUV-based assessment at 4 cycles of chemotherapy J Nucl Med 50 4 2009 527 533
    • (2009) J Nucl Med , vol.50 , Issue.4 , pp. 527-533
    • Itti, E.1    Lin, C.2    Dupuis, J.3    Paone, G.4    Capacchione, D.5    Rahmouni, A.6
  • 4
    • 34548587491 scopus 로고    scopus 로고
    • Overview of early response assessment in lymphoma with FDG-PET
    • M.P. MacManus, J.F. Seymour, and R.J. Hicks Overview of early response assessment in lymphoma with FDG-PET Cancer Imaging 7 2007 10 18
    • (2007) Cancer Imaging , vol.7 , pp. 10-18
    • Macmanus, M.P.1    Seymour, J.F.2    Hicks, R.J.3
  • 5
    • 1842529563 scopus 로고    scopus 로고
    • Application of dynamic contrast-enhanced MRI to differentiate malignant lymphoma from squamous cell carcinoma in the head and neck
    • J. Asaumi, Y. Yanagi, H. Konouchi, M. Hisatomi, H. Matsuzaki, and K. Kishi Application of dynamic contrast-enhanced MRI to differentiate malignant lymphoma from squamous cell carcinoma in the head and neck Oral Oncol 40 6 2004 579 584
    • (2004) Oral Oncol , vol.40 , Issue.6 , pp. 579-584
    • Asaumi, J.1    Yanagi, Y.2    Konouchi, H.3    Hisatomi, M.4    Matsuzaki, H.5    Kishi, K.6
  • 6
    • 0034997733 scopus 로고    scopus 로고
    • Mediastinal lymphoma: Quantitative changes in gadolinium enhancement at mr imaging after treatment
    • Alain Rahmouni, Marine Divine, Eric Lepage, N. Jazaerli, K. Belhadj, and P. Gaulard et al. Mediastinal lymphoma: quantitative changes in gadolinium enhancement at mr imaging after treatment Radiology 219 2001 621 628
    • (2001) Radiology , vol.219 , pp. 621-628
    • Rahmouni, A.1    Divine, M.2    Lepage, E.3    Jazaerli, N.4    Belhadj, K.5    Gaulard, P.6
  • 7
    • 0345446717 scopus 로고    scopus 로고
    • Bone marrow with diffuse tumor infiltration in patients with lymphoproliferative diseases: Dynamic gadolinium-enhanced MR imaging
    • Alain Rahmouni, Jean-Luc Montazel, Marine Divine, E. Lepage, K. Belhadj, and P. Gaulard et al. Bone marrow with diffuse tumor infiltration in patients with lymphoproliferative diseases: dynamic gadolinium-enhanced MR imaging Radiology 229 2003 710 717
    • (2003) Radiology , vol.229 , pp. 710-717
    • Rahmouni, A.1    Montazel, J.2    Divine, M.3    Lepage, E.4    Belhadj, K.5    Gaulard, P.6
  • 8
    • 84899966595 scopus 로고    scopus 로고
    • Interim 18F-FDG PET SUVmax reduction is superior to visual analysis in predicting outcome early in hodgkin lymphoma patients
    • (February) [Epub ahead of print]
    • Rossi C, Kanoun S, Berriolo-Riedinger A, Dygai-Cochet I, Humbert O, Legouge C, et al. Interim 18F-FDG PET SUVmax reduction is superior to visual analysis in predicting outcome early in hodgkin lymphoma patients. J Nucl Med 2014;(February) [Epub ahead of print].
    • (2014) J Nucl Med
    • Rossi, C.1    Kanoun, S.2    Berriolo-Riedinger, A.3    Dygai-Cochet, I.4    Humbert, O.5    Legouge, C.6
  • 9
    • 80052213872 scopus 로고    scopus 로고
    • Whole-body diffusion-weighted imaging: The added value to whole-body MRI at initial diagnosis of lymphoma
    • J. Gu, T. Chan, J. Zhang, A.Y. Leung, Y.L. Kwong, and P.L. Khong Whole-body diffusion-weighted imaging: the added value to whole-body MRI at initial diagnosis of lymphoma AJR Am J Roentgenol 197 3 2011 W384 W391
    • (2011) AJR Am J Roentgenol , vol.197 , Issue.3
    • Gu, J.1    Chan, T.2    Zhang, J.3    Leung, A.Y.4    Kwong, Y.L.5    Khong, P.L.6
  • 10
    • 79958843357 scopus 로고    scopus 로고
    • Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients
    • G. Abdulqadhr, D. Molin, G. Aström, M. Suurküla, L. Johansson, and H. Hagberg et al. Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients Acta Radiol 52 2 2011 173 180
    • (2011) Acta Radiol , vol.52 , Issue.2 , pp. 173-180
    • Abdulqadhr, G.1    Molin, D.2    Aström, G.3    Suurküla, M.4    Johansson, L.5    Hagberg, H.6
  • 11
    • 79954829586 scopus 로고    scopus 로고
    • Whole-body diffusion-weighted imaging with apparent diffusion coefficient mapping for treatment response assessment in patients with diffuse large B-cell lymphoma: Pilot study
    • C. Lin, E. Itti, A. Luciani, B. Zegai, S.J. Lin, and F. Kuhnowski et al. Whole-body diffusion-weighted imaging with apparent diffusion coefficient mapping for treatment response assessment in patients with diffuse large B-cell lymphoma: pilot study Invest Radiol 46 5 2011 341 349
    • (2011) Invest Radiol , vol.46 , Issue.5 , pp. 341-349
    • Lin, C.1    Itti, E.2    Luciani, A.3    Zegai, B.4    Lin, S.J.5    Kuhnowski, F.6
  • 12
    • 0343239071 scopus 로고    scopus 로고
    • Response criteria for NHL: Importance of 'normal' lymph node size and correlations with response rates
    • A.J. Grillo-López, B.D. Cheson, S.J. Horning, B.A. Peterson, W.D. Carter, and C.L. Varns et al. Response criteria for NHL: importance of 'normal' lymph node size and correlations with response rates Ann Oncol 11 4 2000 399 408
    • (2000) Ann Oncol , vol.11 , Issue.4 , pp. 399-408
    • Grillo-López, A.J.1    Cheson, B.D.2    Horning, S.J.3    Peterson, B.A.4    Carter, W.D.5    Varns, C.L.6
  • 14
    • 79957497589 scopus 로고    scopus 로고
    • Dose-escalation with beacopp escalated is superior to ABVD in the combined-modality treatment of early unfavorable hodgkin lymphoma: Final analysis of the German Hodgkin Study Group (GHSG) HD14 Trial
    • [Abstract 765]
    • Engert A, Borchmann P, Pluetschow A, et al. Dose-escalation with beacopp escalated is superior to ABVD in the combined-modality treatment of early unfavorable hodgkin lymphoma: final analysis of the German Hodgkin Study Group (GHSG) HD14 Trial. Blood (ASH Annual Meeting Abstracts) 2010;116 [Abstract 765].
    • (2010) Blood (ASH Annual Meeting Abstracts) , vol.116
    • Engert, A.1    Borchmann, P.2    Pluetschow, A.3
  • 15
    • 77952477025 scopus 로고    scopus 로고
    • Standard International prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era
    • M. Ziepert, D. Hasenclever, E. Kuhnt, B. Glass, N. Schmitz, and M. Pfreundschuh et al. Standard International prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era J Clin Oncol 28 14 2010 2373 2380
    • (2010) J Clin Oncol , vol.28 , Issue.14 , pp. 2373-2380
    • Ziepert, M.1    Hasenclever, D.2    Kuhnt, E.3    Glass, B.4    Schmitz, N.5    Pfreundschuh, M.6
  • 16
    • 0027731029 scopus 로고
    • Early response monitoring in malignant lymphoma using fluorine-18 fluorodeoxyglucose single-photon emission tomography
    • O.S. Hoekstra, A. van Lingen, G.J. Ossenkoppele, R. Golding, and G.J. Teule Early response monitoring in malignant lymphoma using fluorine-18 fluorodeoxyglucose single-photon emission tomography Eur J Nucl Med 20 12 1993 1214 1217
    • (1993) Eur J Nucl Med , vol.20 , Issue.12 , pp. 1214-1217
    • Hoekstra, O.S.1    Van Lingen, A.2    Ossenkoppele, G.J.3    Golding, R.4    Teule, G.J.5
  • 17
    • 80052213872 scopus 로고    scopus 로고
    • Whole-body diffusion-weighted imaging: The added value to whole-body MRI at initial diagnosis of lymphoma
    • H.M. van Ufford, T.C. Kwee, F.J. Beek, T. Takahara, C.S. Uiterwaal, and M.B. Bierings et al. Whole-body diffusion-weighted imaging: the added value to whole-body MRI at initial diagnosis of lymphoma AJR Am J Roentgenol 197 3 2011 W384 W391
    • (2011) AJR Am J Roentgenol , vol.197 , Issue.3
    • Van Ufford, H.M.1    Kwee, T.C.2    Beek, F.J.3    Takahara, T.4    Uiterwaal, C.S.5    Bierings, M.B.6
  • 18
    • 84860611221 scopus 로고    scopus 로고
    • Whole-body MR-DWIBS vs. [(18)F]-FDG-PET/CT in the study of malignant tumors: A retrospective study
    • (July) [Epub ahead of print]
    • Cafagna D, Rubini G, Iuele F, Maggialetti N, Notaristefano A, Pinto D, et al. Whole-body MR-DWIBS vs. [(18)F]-FDG-PET/CT in the study of malignant tumors: a retrospective study. Radiol Med 2011;(July) [Epub ahead of print].
    • (2011) Radiol Med
    • Cafagna, D.1    Rubini, G.2    Iuele, F.3    Maggialetti, N.4    Notaristefano, A.5    Pinto, D.6
  • 19
    • 59849091285 scopus 로고    scopus 로고
    • Monitoring response to chemotherapy of non-Hodgkin's lymphoma xenografts by T(2)-weighted and diffusion-weighted MRI
    • M.Q. Huang, S. Pickup, D.S. Nelson, H. Qiao, H.N. Xu, and L.Z. Li et al. Monitoring response to chemotherapy of non-Hodgkin's lymphoma xenografts by T(2)-weighted and diffusion-weighted MRI NMR Biomed 21 10 2008 1021 1029
    • (2008) NMR Biomed , vol.21 , Issue.10 , pp. 1021-1029
    • Huang, M.Q.1    Pickup, S.2    Nelson, D.S.3    Qiao, H.4    Xu, H.N.5    Li, L.Z.6
  • 20
    • 79960485182 scopus 로고    scopus 로고
    • Whole-body diffusion-weighted MRI with apparent diffusion coefficient mapping for early response monitoring in multiple myeloma: Preliminary results
    • M. Horger, K. Weisel, W. Horger, A. Mroue, M. Fenchel, and M. Lichy Whole-body diffusion-weighted MRI with apparent diffusion coefficient mapping for early response monitoring in multiple myeloma: preliminary results AJR Am J Roentgenol 196 6 2011 W790 W795
    • (2011) AJR Am J Roentgenol , vol.196 , Issue.6
    • Horger, M.1    Weisel, K.2    Horger, W.3    Mroue, A.4    Fenchel, M.5    Lichy, M.6
  • 21
    • 2642613656 scopus 로고    scopus 로고
    • Positron emission tomography in non-Hodgkin's lymphoma: Assessment of chemotherapy with fluorodeoxyglucose
    • W. Römer, A.R. Hanauske, S. Ziegler, R. Thödtmann, W. Weber, and C. Fuchs et al. Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose Blood 91 12 1998 4464 4471
    • (1998) Blood , vol.91 , Issue.12 , pp. 4464-4471
    • Römer, W.1    Hanauske, A.R.2    Ziegler, S.3    Thödtmann, R.4    Weber, W.5    Fuchs, C.6
  • 22
    • 0027363708 scopus 로고
    • Early treatment response in malignant lymphoma, as determined by planar fluorine-18-fluorodeoxyglucose scintigraphy
    • O.S. Hoekstra, G.J. Ossenkoeppele, R. Golding, A. van Lingen, G.W. Visser, and G.J. Teule et al. Early treatment response in malignant lymphoma, as determined by planar fluorine-18-fluorodeoxyglucose scintigraphy J Nucl Med 34 1993 1706 1710
    • (1993) J Nucl Med , vol.34 , pp. 1706-1710
    • Hoekstra, O.S.1    Ossenkoeppele, G.J.2    Golding, R.3    Van Lingen, A.4    Visser, G.W.5    Teule, G.J.6
  • 23
    • 0027442958 scopus 로고
    • Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: Initial evaluation
    • R.L. Wahl, K. Zasadny, M. Helvie, G.D. Hutchins, B. Weber, and R. Cody Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation J Clin Oncol 11 11 1993 2101 2111
    • (1993) J Clin Oncol , vol.11 , Issue.11 , pp. 2101-2111
    • Wahl, R.L.1    Zasadny, K.2    Helvie, M.3    Hutchins, G.D.4    Weber, B.5    Cody, R.6
  • 24
    • 84882250460 scopus 로고    scopus 로고
    • Comparison of different MRI sequences in lesion detection and early response evaluation of diffuse large B-cell lymphoma - A whole-body MRI and diffusion-weighted imaging study
    • (March) doi:10.1002/nbm.2933 [Epub ahead of print]
    • Wu WE, Nerisho S, Dastidar P, Ryymin P, Järvenpää R, Pertovaara H, et al. Comparison of different MRI sequences in lesion detection and early response evaluation of diffuse large B-cell lymphoma - a whole-body MRI and diffusion-weighted imaging study. NMR Biomed 2013;(March) doi:10.1002/nbm.2933 [Epub ahead of print].
    • (2013) NMR Biomed
    • Wu We, N.1
  • 25
    • 34547402187 scopus 로고    scopus 로고
    • Diffusion and perfusion imaging in subacute neurotoxicity following high-dose methotrexate
    • A.F. Eichler, T.T. Batchelor, and J.W. Henson Diffusion and perfusion imaging in subacute neurotoxicity following high-dose methotrexate Neuro Oncol 9 3 2007 373 377
    • (2007) Neuro Oncol , vol.9 , Issue.3 , pp. 373-377
    • Eichler, A.F.1    Batchelor, T.T.2    Henson, J.W.3
  • 26
    • 70349680664 scopus 로고    scopus 로고
    • Diffusion-weighted MRI of advanced hepatocellular carcinoma during sorafenib treatment: Initial results
    • C. Schraml, N.F. Schwenzer, P. Martirosian, M. Bitzer, U. Lauer, and C.D. Claussen et al. Diffusion-weighted MRI of advanced hepatocellular carcinoma during sorafenib treatment: initial results AJR Am J Roentgenol 193 4 2009 W301 W307
    • (2009) AJR Am J Roentgenol , vol.193 , Issue.4
    • Schraml, C.1    Schwenzer, N.F.2    Martirosian, P.3    Bitzer, M.4    Lauer, U.5    Claussen, C.D.6
  • 27
    • 61349123591 scopus 로고    scopus 로고
    • Diffusion-weighted magnetic resonance imaging as a cancer biomarker: Consensus and recommendations
    • A.R. Padhani, G. Liu, D.M. Koh, T.L. Chenevert, H.C. Thoeny, and T. Takahara et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations Neoplasia 11 2 2009 102 125
    • (2009) Neoplasia , vol.11 , Issue.2 , pp. 102-125
    • Padhani, A.R.1    Liu, G.2    Koh, D.M.3    Chenevert, T.L.4    Thoeny, H.C.5    Takahara, T.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.